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Abstract
Introduction: In response to reported difficulties in selecting a Medicare Part D prescription drug plan, we designed a
patient-centered online Part D plan selection tool (CHOICE1.0) to simplify the selection process and to provide personalized,
expert recommendations. Methods: This ethnographic comparative usability study observed 44 patients using the first
version of the tool during Medicare 2016 Open Enrollment. Participants were observed as they chose their drug plan using
Medicare.gov and 1 of 3 versions of CHOICE1.0 that varied in amount of expert guidance. Descriptive statistics were used to
analyze exit survey data. The observations were video-recorded, and field notes were analyzed thematically. Results: Par-
ticipants were significantly more satisfied with CHOICE1.0 for choosing a plan, understanding information, and ease of use
compared to Medicare.gov. Those using expert versions of CHOICE1.0 were more likely to indicate their intention to switch
plans than those using Medicare.gov, though they wanted to know the source and content. Conclusion: The more patient-
centered prescription drug choice tool improved user experience and enabled users to choose plans more consistent with
expert recommendations.
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Introduction
Choosing a Medicare Part D prescription drug plan is com-
plicated. Complex plan features, including formularies,
deductibles, coinsurance rates, out-of-pocket maximums,
and complex cost sharing arrangements (“donut hole”), are
difficult for many Americans—particularly older adults—to
understand (1). In addition, people eligible for Part D cov-
erage usually must choose from upward of 30 different plans
(2), and many studies have documented that decision-
making quality declines as choice set increases (3–6).
Finally, the complexity of the choice is compounded by the
varying health needs of each individual, so the plan that best
covers one person’s needs may differ from that of that per-
son’s spouse or friend.
Correspondingly, many Medicare beneficiaries find
choosing a prescription drug plan frustrating and confusing
(3-6). In a nationally representative survey of older adults,
62% of those who did not enroll in a Part D plan and more
than half of those who did enroll agreed with the statement
that “I had difficulty understanding how Medicare Part D
works and what savings it would provide (4).” Reports from
recent focus groups suggest that while more beneficiaries are
using the Internet to research and compare plan options than
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in previous years, the annual open enrollment process for
selecting or changing plans still seems to be confusing (7).
These decisions are particularly difficult for less numerate
Medicare beneficiaries (8,9). As such, patients are not select-
ing the lowest cost plan for their needs (10,11), which could
potentially save them several hundred dollars a year, a sig-
nificant amount for retirees on a fixed income. Previous
research has shown that even small “nudges” can affect plan
selection. For example, a simple letter moved people to
lower cost plans, resulting in potential savings of $US100
a year (12).
Older adults utilize a wide range of resources to assist
them in selecting a Medicare Part D plan. Some turn to
experts, such as the Health Insurance Counseling and Advo-
cacy Program and insurance brokers, while others refer to
books, brochures, or the Internet for guidance (13). One
focus group study regarding the experiences of beneficiaries
selecting a Medicare Part D plan found that the most fre-
quently reported website was the Medicare.gov Plan Finder
tool. Hosted by the Centers for Medicare and Medicaid Ser-
vices (CMS), this interactive online tool has beneficiaries
enter their zip code and current medications and then pro-
vides a list of all the available plans in the region, as well as
their estimated costs and coverage. While some participants
found the CMS tool to be helpful, others described it as
confusing and prone to glitches (13).
To alleviate the reported difficulties with the CMS online
tool and in response to evidence that older adults were more
likely to switch plans when provided with easy-to-access
evidence on the costs associated with different plans (12),
we developed a new online Medicare Part D selection tool,
CHOICE1.0, with a multidisciplinary team of researchers at
Palo Alto Medical Foundation Research Institute and
Stanford University, as well as a software developer, user
experience consultant, pharmacist stakeholder, and health IT
executive at Palo Alto Medical Foundation (PAMF) Com-
munity Health Resource Center and patient stakeholders.
Building on findings from our focus group research (13) and
input from stakeholders, CHOICE1.0 incorporates user-
centered design concepts by having a more streamlined
interface and by directly importing beneficiaries’ medica-
tions that are listed in the electronic health record (EHR)
of a large, multispecialty group practice, PAMF.
In our focus group, we also found that older adults wanted
assistance in choosing a plan (13). As a result, we developed
3 versions of CHOICE1.0, each of which varied based on the
extent to which and how they provide the user with perso-
nalized expert recommendations. In all versions, descrip-
tions of the plan features were provided and patients were
able to compare up to 3 plans at a time. In version 1 (Expert
Recommendation), we highlighted 3 expert recommended
plans for each patient based on their likely annual out-of-
pocket spending, including plan premiums and spending on
prescription drugs, and the Medicare star ratings (a measure
of customer satisfaction). In version 2 (Guided Analysis),
instead of explicitly identifying the recommended plan, we
provided patients with a score for each plan based on the
algorithm underlying the expert recommendation. In version
3 (Individual Analysis), we provided information on each of
the features underlying the expert recommendation, but not
the recommendation itself. The expert recommendation was
based on individual cost estimates, including both premium
and expected out-of-pocket spending for prescription drugs,
and a CMS measure of plan quality.
Our objective was to compare the new CHOICE1.0 tool
with CMS’s Medicare.gov Plan Finder, and our hypothesis
was that CHOICE1.0 would make the Medicare Part D pre-
scription drug plan selection process easier for older adults
and direct them to plans that would lower their overall
spending on prescription drugs.
Methods
Participants were patients of PAMF, a large, multispecialty
medical foundation affiliate of Sutter Health, serving over 1
million patients in Northern California. We used survey and
ethnographic methods to compare the experiences of older
adult participants using CHOICE1.0 and the CMS tool dur-
ing Medicare’s 2016 Open Enrollment Period (October 15,
2015, to December 7, 2015). Direct observation is an ideal
method for gaining insight into and understanding of user
needs and is commonly used by innovative product devel-
opers. By observing and documenting the tasks and proce-
dures used by participants, we were able to gain insight into
what worked and what needed to be improved.
Participants were recruited through active and passive
means. Active recruitment occurred by members of the
research team at multiple events and locations, including
an “Introduction to Medicare” lecture, an event at a local
older adult community, blood pressure clinics, and labora-
tories within PAMF clinics. Posters and flyers were placed in
the waiting rooms of family medicine, internal medicine, and
geriatric medicine departments at several PAMF clinics; an
article seeking participants was included in the PAMF
patient newsletter; a request for participants was included
on the online patient portal (My Health Online) homepage;
and an e-mail was sent to the electronic mailing lists of
groups helping older adults (Avenidas Village, a local
aging-in-place organization and a group discussing
“Successful Aging”).
Potential participants were screened by a research team
member either in person or over the phone for the following
eligibility criteria: were of age 66 to 85 at the time of the
study, were a PAMF patient, and had a Medicare Part D plan
(not a Medicare Advantage Plan). If they met all of the
eligibility criteria, they provided the research team member
with their demographic information, which was then used to
extract their medication data from the EpicCare EHR and
input into CHOICE1.0. Participants were asked to bring a
copy of their current medications and dosages to the obser-
vation session to verify the information in CHOICE1.0 and
82 Journal of Patient Experience 6(1)
to enter in the CMS tool. Informed consent was obtained
prior to participation.
Participants sat in front of a computer screen with full
control of the mouse and keyboard while a research team
member observed as they interacted with the tools. Partici-
pants were instructed by the researcher to verbally explain
their thoughts and reactions to the tools as they navigated
the different options. The researcher probed for further
details and clarifications about participant thoughts and
navigation choices.
Each participant sequentially used both CMS and 1 ver-
sion of CHOICE1.0. Participants were randomly assigned
both the order in which they used the tools (either CMS or
CHOICE1.0 first) and which of the 3 versions of
CHOICE1.0 they used. Each participant used 1 tool and
completed a survey about their experience with that tool
and then used the other tool and completed the same survey.
All participants then completed a comparative survey about
their use of the 2 tools (see Figure 1). Survey data were
entered into WorldApp.
Participants did not actually enroll in a plan during the
comparative observation period—instead, they reported
which plan they were likely to choose (their “intended
choice”). Participants could print out lists of and information
about potential plans for later use. They were not given a
time limit to review the information. Instead, they indicated
to the research team member when they were finished, gen-
erally between 1 to 2 hours. Upon completion, they received
a $US100 gift card as a token of appreciation. The protocol
was approved by the institutional review boards at Sutter
Health and Stanford University.
Basic descriptive statistics were used to analyze partici-
pant demographics and survey responses. Statistical signifi-
cance tests were performed to determine differences across
versions of CHOICE1.0 and CMS. The first 3 outcome mea-
sures reflected potential changes in enrollment: “plan
switching,” “enrollment in expert recommended plan,” and
“enrollment in lowest cost plan” (see Table 1). For each of
these measures, we calculated the percentages, that is, the
percentage of participants who chose a different plan than
their original one, the percentage of participants who
enrolled in the expert recommended plan, and the percentage
of participants who enrolled in the lowest cost plan, across
CMS and CHOICE1.0 (overall and version 2 versus version
1 and version 3 versus version 1). To determine “change in
coverage generosity,” we calculated the difference between
the cost of the participant’s original plan, given their current
set of drugs and considering both premium and out-of-pocket
spending for drugs given the plan’s cost sharing structure, and
that of the plan the participant chose on the day of the obser-
vation (Table 1). The other outcome measures reflect aspects
of the participants’ experience in choosing a Medicare Part D
prescription drug plan including how satisfied the patient was
with the chosen plan, how confident the patient was in choos-
ing a plan, how satisfied the patient was with the process of
choosing a plan, how much the patient enjoyed choosing a
plan, and whether the patient would have liked more or less
information. Each of these measures was on a scale of 1 to 4,
with 1 being the highest and 4 being the lowest. For example,
in “How satisfied with plan,” 1 corresponds to being
extremely satisfied and 4 corresponds to being not at all sat-
isfied. Given that this was a small pilot study, we chose a
minimum P value of 0.25 to infer the statistical significance
of intervention effects, instead of relying on the traditional
statistical significance levels (14).
Qualitative Observations
Sessions were video-recorded capturing only the computer
screen and participants’ verbal comments (no faces), and this
was compared with notes taken by the research team mem-
bers. A qualitative researcher coded the field notes through
open coding to identify emergent themes from the data and
for suggestions on how to improve CHOICE1.0.
Results
A total of 44 participants consented and completed the study.
Participants were mostly married, Caucasian/white, edu-
cated (completed college or master’s degree/higher), and
retired (see Table 2).
Participants did not differ significantly in the likelihood
that they would switch plan after using CHOICE1.0 (67%)
compared to after using CMS (60%). There was also no
statistically significant difference in plan switching probabil-
ity across the 3 versions of CHOICE1.0. After using
CHOICE1.0, 71% of participants would enroll in an expert
recommended plan when compared to after using CMS
(49%; P < .05; Table 1). Compared to 86% of participants
who would enroll in an expert recommended plan after using
version 1 of CHOICE1.0, 87% would do so after using ver-
sion 2, which was not statistically different from version 1.
However, only 38% of those who used version 3 would
enroll in an expert recommended plan, which was signifi-
cantly lower than the probability among those after using
version 1 (86%; P < .05). Furthermore, 40% of participants
Figure 1. Diagram and randomization of ethnographic compara-
tive usability study.
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stated an intention to enroll in the lowest cost plan after using
CHOICE1.0, compared to 20% after using CMS (P < .25;
Table 1). Although the probabilities of enrolling in the lowest
cost plan did not differ statistically significantly between ver-
sions 1 (57%) and 2 (47%), the probability was significantly
lower in version 3 (15%) than in version 1 (57%)(P < .05).
Changes in coverage generosity differed between CMS
and CHOICE1.0 as well as between versions of CHOICE1.0.
Compared to what their expenditure would have been if they
had stayed in their original plan, participants would save
$US129 after using the CMS tool compared to an estimated
saving of $US672 after using CHOICE1.0 (P < .25; Table 1).
Potential savings of $US886 from version 1 also differed
from potential savings of $US86 from using version 3 of
CHOICE1.0 (P < .25).
Participants were significantly more satisfied with the
process of choosing a Medicare Part D prescription drug plan
after using CHOICE1.0 (mean ¼ 2.0, standard deviation
[SD] ¼ 1.11) when compared to after using CMS (mean ¼
2.6, SD ¼ 1.03; P < .05; Table 1). Participants reported
having greater enjoyment in the process of choosing a Med-
icare Part D prescription drug plan after using CHOICE1.0
(mean¼ 2.2, SD¼ 1.05) when compared to after using CMS
(mean ¼ 2.9, SD ¼ 1.05; P < .01; Table 1). Participants did
not differ in their opinion on whether they wanted more or
less information after using each tool (Table 1). There were
also no statistically significant differences in these measures
across the 3 versions of CHOICE1.0.
Qualitative Observations
Many participants reported how difficult and confusing
CMS was as it just had too much information for them to
process. One said that it was “mystifying” and another said
“I feel like I should take a college course in how they [all the
parts of Medicare Part D] interrelate.” A third participant
said “I must be dumb” for not understanding one of the terms
(“Original Medicare”) on the CMS Plan Finder.
A participant reported that “the experimental tool
[CHOICE1.0] is better for the technologically inept.” Yet
he, and a few other participants, preferred all of the details
and nuanced information provided by CMS: “I want to see
where the numbers come from—I want to see where the
costs are coming from.”
Participants also made comments regarding the 3 versions
of CHOICE1.0. In terms of the expert recommendation (ver-
sion 1) and guided analysis (version 2), many participants
wanted to know who the “expert” was, as well as more
information about the components involved in making the
recommendations and how the number was calculated. A
few participants in version 1 mentioned that they like how
it presented them with just a few recommended options so
that they did “not have an endless list of choices.”
Discussion
In comparing CHOICE1.0 and CMS’s Plan Finder, partici-
pants had greater satisfaction with the selection process in
CHOICE1.0 and found it easy to use. Many user-centered
features of CHOICE1.0 improved patient experience, which
enabled participants to choose plans more consistent with
expert recommendations. A design consultant, reviewing the
2 tools, likened CHOICE1.0 to an Apple product, meaning
that the focus was on ease of use, and CMS to a PC product,
requiring greater technical capability on the part of the user.
CHOICE1.0 resulted in more than $US500 of potential
Table 1. CMS and CHOICE1.0 Survey Results.a
Variable CMS
CHOICE1.0
All CHOICE1.0
versionsb
Version 1: Expert
Recommendation
Version 2: Guided
Analysisc
Version 3: Individual
Analysisc
Plan switching, % 60 67 71 67 62
Enrollment in expert
recommended plan, %
49 71d 86 87 38d
Enrollment in lowest cost plan, % 20 40e 57 47 15d
Change in coverage generosity,
mean (SD) ($US)
129 (588) 672e (1,839) 886 (2,152) 1015 (2,316) 86e (125)
How satisfied with plan, mean (SD)f 1.76 (0.69) 1.81 (0.76) 1.93 (0.96) 1.87 (0.64) 1.62 (0.65)
How confident, mean (SD)f 1.95 (0.76) 2.10 (0.91) 2.14 (0.95) 2.13 (0.99) 2.00 (0.82)
How satisfied with process, mean (SD)f 2.60 (1.30) 2.00c (1.11) 1.80 (1.08) 2.14 (1.17) 2.07 (1.14)
How much enjoyment, mean (SD)f 2.85 (1.05) 2.20g (1.05) 2.40 (1.18) 2.00 (1.07) 2.21 (0.89)
More or less information, mean (SD)f 1.95 (0.79) 1.83 (0.66) 1.93 (0.73) 1.87 (0.74) 1.69 (0.48)
Number of participants 44 44 15 15 14
aSource: Medicare Part D Comparative Usability Study Questionnaires.
bCompared all versions of CHOICE1.0 with CMS Plan Finder.
cCHOICE1.0 versions 2 and 3 was compared to CHOICE1.0 version 1, respectively.
dP < .05.
eP < .25.
fScale of 1 to 4, where 1 ¼ more and 4 ¼ less.
gP < .01.
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savings. The usability test provided findings similar to a
previous behavioral economic experiment (12) that using
choice architecture(15) where small modifications in how
the information is presented (eg, providing some specific
recommendations) can have a significant impact on plan
selection and user experience.
A main limitation of this study is the demographics of the
participant population (highly educated and high income).
The choice of our study population was driven both by the
types of patients who chose to participate in the study and the
characteristics of the population for which we had potential
access to electronic information on prescription drug usage
for use in the online tool. This highly educated and relatively
technology savvy population potentially has more experi-
ence navigating online websites than the average older adult
and was well positioned to identify areas in CHOICE1.0 that
needed improvement to make CHOICE2.0 even more user-
friendly. Future research should examine the attractiveness
and effects of expert recommendations and online decision-
making tools for more heterogeneous users based on char-
acteristics such as race/ethnicity, gender, education, and
income to determine whether expert recommendations have
differing impacts on different segments of the population.
The findings from this comparative usability study were
used to guide further refinement of the tool CHOICE2.0 for a
3-arm randomized control trial that was completed during
the 2017 Open Enrollment period (October 15, 2016, to
December 7, 2016). Given the similar enrollment levels and
change in coverage generosity between expert recommended
and guided analysis, we decided that, while patients
appeared to value the expert recommendation, the study did
not provide evidence of which version of the recommenda-
tion they preferred. Thus, in our trial, we decided to merge
the 2 expert recommendation arms, providing both an expli-
cit plan recommendation and the expert scores. The results
of the trial will be reported separately.
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